9 Grants
2021
Epigenetic Mechanisms of Drug Resistance in Renal Cell Carcinoma
Haas, Naomi B⋅Hollenhorst, Peter C and PILI, ROBERTO
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 7R01CA224342-04), $468,240USD, 2021-03-20 -- 2023-01-31
 
Molecular mechanisms specific to ETS transcription factors that drive oncogenesis
Hollenhorst, Peter C
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA204121-05), $464,469USD, 2017-06-01 -- 2022-05-31
2020
Epigenetic mechanisms of drug resistance in renal cell carcinoma
Haas, Naomi B⋅Hollenhorst, Peter C and Pili, Roberto
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA224342-03), $406,936USD, 2018-02-01 -- 2023-01-31
 
Molecular mechanisms specific to ETS transcription factors that drive oncogenesis
Hollenhorst, Peter C
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA204121-04), $255,779USD, 2017-06-01 -- 2022-05-31
2019
Epigenetic mechanisms of drug resistance in renal cell carcinoma
Haas, Naomi B⋅Hollenhorst, Peter C and Pili, Roberto
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA224342-02), $417,407USD, 02/01/2018 -- 01/31/2023
 
Molecular mechanisms specific to ETS transcription factors that drive oncogenesis
Hollenhorst, Peter C
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA204121-03), $349,319USD, 06/01/2017 -- 05/31/2022
2018
Epigenetic mechanisms of drug resistance in renal cell carcinoma
Haas, Naomi B⋅Hollenhorst, Peter C and Pili, Roberto
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA224342-01), $460,363USD, 02/01/2018 -- 01/31/2023
 
Molecular mechanisms specific to ETS transcription factors that drive oncogenesis
Hollenhorst, Peter C
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA204121-02), $360,124USD, 06/01/2017 -- 05/31/2022
2017
Molecular mechanisms specific to ETS transcription factors that drive oncogenesis
Hollenhorst, Peter C
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA204121-01A1), $359,523USD, 06/01/2017 -- 05/31/2022